[The statement of Polish Gynecological Society Experts on the etiology and treatment of recurrent vulvovaginal candidiasis].

In: Ginekologia polska · 2011 · vol. 82(11) , pp. 869–73 · PMID:22384623 · W4292352194
article OA: green CC0
🔓 Open OA copy View on OpenAlex View on PubMed

Abstract

Vulvovaginal infection is the most common cause of gynecological problems in sexually active women. Knowledge about pharmacological properties of drugs used in treatment recurrent vulvovaginal candidiasis allows for tailoring therapy to each patient. Fluconazole is modern and up to date option for treatment of recurrent vulvovaginal candidiasis. Short- and long-term therapeutic efficacy of fluconazole was confirmed in numerous high reliability clinical trials. Good tolerance, high effectiveness and high level of patient's acceptance gives the specialist powerful and efficient tool for management of recurrent Candida infections.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK